Theories on the Pathogenesis of Endometriosis

Endometriosis: Science and Practice

Volumn , Issue , 2012, Pages 42-53

  Nap, Annemiek W ^a  

^a RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

Endometriosis; in situ development; Induction; Pathogenesis; Retrograde menstruation; Theories; Transplantation

Indexed keywords

EID: 84879964438     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444398519.ch5     Document Type: Chapter

References (136)

1. Von Rokitansky C. Ueber Uterusdrusen-Neubildung in Uterus- und Ovarial-Sarcomen. Ztschr KK Gesellsch Der Aerzte zu Wien 1860;37:577-581.
2. Cullen TS. Adeno-myoma uteri diffusum benignum. Johns Hopkins Hosp Bull 1896;6:133-137.
3. Sampson JA. Perforating hemorrhagic (chocolate) cysts of the ovary: their importance and especially their relation to pelvic adenomas of endometrial type (adenomyoma of the uterus, rectovaginal septum, sigmoid, etc). Arch Surg 1921;3:245-323.
4. Sampson JA. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927;14:422-469.
5. Sampson JA. The development of the implantation theory for the origin of peritoneal endometriosis. Am J Obstet Gynecol 1940;40: 549-557.
6. Koninckx PR. Is mild endometriosis a condition occurring intermittently in all women? Hum Reprod 1994;9:2202-2205.
7. Scott RB, Te Linde RW, Wharton LR Jr. Further studies on experimental endometriosis. Am J Obstet Gynecol 1953;66:1082-1099.
8. Nisolle M, Donnez J. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril 1997;68:585-596.
9. Lauchlan SC. The secondary Mullerian system. Obstet Gynecol Surv 1972;27:133-146.
10. Batt RE, Smith RA, Buck Louis GM et al. Mullerianosis. Histol Histopathol 2007;22:1161-1166.
11. Nawroth F, Rahimi G, Nawroth C et al. Is there an association between septate uterus and endometriosis? Hum Reprod 2006;2:542-544.
12. Mok-Lin EY, Wolfberg A, Hollinquist H et al. Endometriosis in a patient with Mayer-Rokitansky-Kuster-Hauser syndrome and complete uterine agenesis: evidence to support the theory of coelomic metaplasia. J Pediatr Adolesc Gynecol 2010;23(1):e35-37.
13. Batt RE, Mitwally MFM. Endometriosis from thelarche to midteens: pathogenesis and prognosis, prevention and pedagogy. J Pediatr Adolesc Gynecol 2003;16:337-347.
14. Signorile PG, Baldi F, Bussani R et al. Ectopic endometrium in human foetuses is a common event and sustains the theory of mullerianosis in the pathogenesis of endometriosis, a disease that predisposes to cancer. J Exp Clin Cancer Res 2009;28:49.
15. Meyer R. Ueber eine adenomatose Wuchenrung der Serosa in einer Bauchnarbe. Z Geburtsh Gynakol 1903;49:32-41.
16. Meyer R. Ueber Stand der frage der Adenomyositis und Adenomyome im Allgemeinen und ins Besondere uber Adenomyositis seroepithelialis und Adenomyometritis sarcomatosa. Zentralbl Gynakol 1919;36: 745-750.
17. Novak E. Pelvic endometriosis. Spontaneous rupture of endometrial cysts, with a report of three cases. Am J Obstet Gynecol 1931;22: 826-837.
18. Suginami H. A reappraisal of the coelomic metaplasia theory by reviewing endometriosis occurring in unusual sites and instances. Am J Obstet Gynecol 1991;165:214-218.
19. Levander G, Normann P. The pathogenesis of endometriosis. An experimental study. Acta Obstet Gynecol Scand 1955;34:366-398.
20. Merrill JA. Endometrial induction of endometriosis across millipore filters. Am J Obstet Gynecol 1996;94:780-789.
21. Javert CT. Pathogenesis of endometriosis based on endometrial homeoplasia, direct extension, exfoliation and implantation, lymphatic and haematogenic metastasis. Cancer 1949;2:399-410.
22. Ridley JH. The histogenesis of endometriosis. A review of facts and fancies. Obstet Gynecol Surv 1968;23:1-35.
23. Victory R, Diamond MP, Johns DA. Villar's node: a case report and systematic review of endometriosis externa of the umbilicus. J Minim Invasive Gynecol 2007;14:23-32.
24. Teng CC, Yang HM, Chen KF et al. Abdominal wall endometriosis: an overlooked but possibly preventable complication. Taiwan J Obstet Gynecol 2008;47.42-48.
25. Halme J, Hammond MG, Hulka JF et al. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol 1984;64:151-154.
26. Kruitwagen RFPM, Poels LG, Willemsen WNP et al. Endometrial epithelial cells in peritoneal fluid during the early follicular phase. Fertil Steril 1991;55:297-303.
27. Koks CAM, Dunselman GAJ, de Goeij AFPM et al. Evaluation of a menstrual cup to collect shed endometrium for in vitro studies. Fertil Steril 1997;68:560-564.
28. Jenkins S, Olive DL, Haney AF. Endometriosis: pathogenetic implications of the anatomic distribution. Obstet Gynecol 1968;67: 355-358.
29. Vercellini P, Abbiati A, Vigano P et al. Asymmetry in distribution of diaphragmatic endometriotis lesions: evidence in favour of the menstrual reflux theory. Hum Reprod 2007;22:2359-2367.
30. Vercellini P, Aimi G, de Giorgi O et al. Is cystic ovarian endometriosis an asymmetric disease? Br J Obstet Gynaecol 1998;105:1018-1021.
31. Maas JWM, Groothuis PG, Dunselman GAJ et al. Development of endometriosis-like lesions after transplantation of human endometrial fragments onto the chick embryo chorioallantoic membrane model. Hum Reprod 2001;16:627-631.
32. Nap AW, Groothuis PG, Demir AY et al. Tissue integrity is essential for ectopic implantation of human endometrium in the chicken chorioallantoic membrane. Hum Reprod 2003;18:30-34.
33. Groothuis PG, Koks CAM, de Goeij AFPM et al. Adhesion of human endometrial fragments to peritoneum in vitro. Fertil Steril 1999;71: 1119-1124.
34. Koks CAM, Groothuis PG, Dunselman GAJ et al. Adhesion of shed menstrual tissue in an in-vitro model using amnion and peritoneum: a light and electron microscopic study. Hum Reprod 1999;14:816-822.
35. Dunselman GAJ, Groothuis PG, de Goeij AFPM et al. The mesothelium, Teflon or Velcro? Hum Reprod 2001;16:605-607.
36. Koks CAM, Demir-Weusten AY, Groothuis PG et al. Menstruum induces changes in mesothelial cell morphology. Gynaecol Obstet Invest 2000;50:13-18.
37. Demir-Weusten AY, Groothuis PG, Dunselman GAJ et al. Morphological changes in mesothelial cells induced by shed menstrual endometrium in vitro are not primarily due to apoptosis or necrosis. Hum Reprod 2000;15:1462-1468.
38. Demir AY, Groothuis PG, Nap AW et al. Menstrual effluent induces epithelial to mesenchymal transitions in mesothelial cells. Hum Reprod 2004;19:21-29.
39. Stetler-Stevenson WG, Liotta LA, Kleiner DE. Extracellular matrix 6: role of matrix metalloproteinases in tumour invasion and metastasis. FASEB J 1993;7:1434-1444.
40. Curran S, Murray GI. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 2000;36:1621-1630.
41. Tabibzadeh S. Patterns of expression of integrin molecules in human endometrium throughout the menstrual cycle. Hum Reprod 1992;7:876-882.
42. Van der Linden PJQ, de Goeij AFPM, Dunselman GAJ et al. Expression of cadherins and integrins in human endometrium throughout the menstrual cycle. Fertil Steril 1995;63:1210-1216.
43. Lessey BA. Endometrial integrins and the establishment of uterine receptivity. Hum Reprod 1998;13 suppl 3:247-258.
44. Lessey BA, Castelbaum AJ, Sawin SW et al. Aberrant integrin expression in the endometrium of women with endometriosis. J Clin Endocrinol Metab 1994;79:643-649.
45. Starzinski-Powitz A, Handrow-Metzmacher H, Kotzian S. The putative role of cell-adhesion molecules in endometriosis: can we learn from tumour metastasis? Molec Med Today 1999;5:304-309.
46. Van der Linden PJQ, de Goeij AFPM, Dunselman GAJ et al. Expression of integrins and E-cadherin in cells from menstrual effluent, endometrium, peritoneal fluid, peritoneum and endometriosis. Fertil Steril 1994;61:85-90.
47. Guilford P. E-cadherin downregulation in cancer: fuel on the fire? Molec Med Today 1999;5:172-177.
48. Gaetje R, Kotzian S, Hermann G et al. Nonmalignant epithelial cells, potentially invasive in human endometriosis, lack the tumour suppressor molecule E-cadherin. Am J Pathol 1997;150:461-467.
49. Creemers EEJM, Cleutjens JPM, Smits JFM et al. Matrix metalloproteinase inhibition after myocardial infarction. A new approach to prevent heart failure? Circ Res 2001;89:201-210.
50. Malik N, Greenfield BW, Wahl AF et al. Activation of human monocytes through CD40 induces matrix metalloproteinases. J Immunol 1996;156:3952-3960.
51. Schonbeck U, Mach F, Sukhova GK et al. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? Circ Res 1997;81:448-454.
52. Murphy G, Willenbrock F, Crabbe T et al. Regulation of matrix metalloproteinase activity. Ann NY Acad Sci 1994;732:31-41.
53. Nagase H. Activation mechanisms of matrix metalloproteinases. Biol Chem 1997;378:151-160.
54. Marbaix E, Kokorine I, Henriet P et al. The expression of interstitial collagenase in human endometrium is controlled by progesterone and by oestradiol and is related to menstruation. Biochem J 1995;305:1027-1030.
55. Hulboy DL, Rudolph LA, Matrisian LM. Matrix metalloproteinases as mediators of reproductive function. Molec Hum Reprod 1997;3:27-45.
56. Rodgers WH, Matrisian LM, Giudice LC et al. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest 1994;94:946-953.
57. Bruner KL, Eisenberg E, Gorstein F et al. Progesterone and transforming growth factor-ß co-ordinately regulate suppression of endometrial matrix metalloproteinases in a model of experimental endometriosis. Steroids 1999;64:648-653.
58. Spuijbroek MDEH, Dunselman GAJ, Menheere PPCA et al. Early endometriosis invades the extracellular matrix. Fertil Steril 1992;58: 929-933.
59. Clark DA. Cytokines in uterine bleeding. In Alexander NJ, d'Arcangues C (eds) Steroid Hormones and Uterine Bleeding. Washington, DC: American Association for the Advancement of Science, 1992, pp. 263-275.
60. Osteen KG, Bruner-Tran KL, Keller NR et al. Progesterone-mediated endometrial maturation limits matrix metalloproteinase (MMP) expression in an inflammatory-like environment: a regulatory system altered in endometriosis. Ann NY Acad Sci 2002;955:37-47.
61. Salamonsen LA, Woolley DE. Matrix metalloproteinases in normal menstruation. Hum Reprod 1996;11(Suppl 2):124-133.
62. Bruner KL, Matrisian LM, Rodgers WH et al. Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. J Clin Invest 1997;99:2851-2857.
63. Nap AW, Dunselman GAJ, de Goeij AFPM et al. Inhibiting MMP activity prevents the development of endometriosis in the chicken chorioallantoic membrane model. Hum Reprod 2004;19:2180-2187.
64. Folkman J. Tumor angiogenesis. Adv Cancer Res 1985;43:175-203.
65. Griffioen AW, Molema G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharm Rev 2000;52:237-268.
66. McLaren J. Vascular endothelial growth factor and endometriotic angiogenesis. Hum Reprod Update 2000;6:45-55.
67. Charnock-Jones DS, Sharkey AM, Rajput-Williams J et al. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol Reprod 1993;48:1120-1128.
68. Smith SK. Regulation of angiogenesis in the endometrium. Trends Endocrinol Metab 2001;12:147-151.
69. Donnez J, Smoes P, Gillerot S et al. Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 1998;13:1686-1690.
70. Wingfield M, Macpherson A, Healy DL et al. Cell proliferation is increased in the endometrium of women with endometriosis. Fertil Steril 1995;64:340-346.
71. Matsuzaki S, Canis M, Murakami T et al. Immunohistochemical analysis of the role of angiogenic status in the vasculature of peritoneal endometriosis. Fertil Steril 2001;76:712-716.
72. Maas JWM, Le Noble FAC, Dunselman GAJ et al. The chick embryo chorioallantoic membrane as a model to investigate the angiogenic properties of human endometrium. Gynecol Obstet Invest 1999;48: 108-112.
73. Hull ML, Charnock-Jones DS, Chan CLK et al. Antiangiogenic agents are effective against endometriosis. J Clin Endocrinol Metab 2003;88:2889-2899.
74. Nap AW, Dunselman GAJ, Griffioen AW et al. Angiostatic agents prevent the development of endometriosis-like lesions in the chicken chorioallantoic membrane. Fertil Steril 2005;83:793-795.
75. Nap AW, Griffioen AW, Dunselman GAJ et al. Anti-angiogenesis therapy for endometriosis. J Clin Endocrinol Metab 2004;89:1089-1095.
76. Redwine DB. Was Samspon wrong? Fertil Steril 2002;78:686-693.
77. Donnez J, Squifflet J, Casanas-Roux F et al. Typical and subtle atypical presentations of endometriosis. Obstet Gynecol Clin North Am 2003;30:83-93.
78. Garai J, Molnar V, Varga T et al. Endometriosis: harmful survival of an ectopic tissue. Front Biosci 2006;11:595-619.
79. Leyendecker G, Herbertz M, Kunz G et al. Endometriosis results from the dislocation of basal endometrium. Hum Reprod 2002;17:2725-2736.
80. Leyendecker G, Wildt L, Mall G. The pathophysiology of endometriosis and adenomyosis: tissue injury and repair. Arch Gynecol Obstet 2009;280:529-538.
81. Kitawaki J, Noguchi T, Amatsu T et al. Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Biol Reprod 1997;57:514-519.
82. Noble LS, Simpson ER, Johns A et al. Aromatase expression in endometriosis. J Clin Endocrinol Metab 1996;81:174-179.
83. Noble LS, Takayama K, Zeitoun KM et al. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metab 1997;82:600-606.
84. Zeitoun K, Takayama K, Sasano H et al. Deficient 17ß-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17ß -estradiol. J Clin Endocrinol Metab 1998;83:4474-4480.
85. Takahashi K, Nagata H, Kitao M. Clinical usefulness of determination of estradiol level in the menstrual blood for patients with endometriosis. Nippon Sanka Fujinka Gakkai Zasshi 1989;41: 1849-1850.
86. Bulun SE, Yang S, Fang Z et al. Role of aromatase in endometrial disease. J Ster Biochem Molec Biol 2001;79:19-25.
87. Takayama K, Zeitoun K, Gunby RT et al. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil Steril 1998;69:709-713.
88. Corson SL, Bolognese RJ. Ibuprofen therapy for dysmenorrhea. J Reprod Med 1978;20:246-252.
89. Haney AF, Muscato JJ, Weinberg JB. Peritoneal fluid cell populations in infertility patients. Fertil Steril 1981;35:696-698.
90. Hill JA, Faris HM, Schiff I et al. Characterization of leukocyte subpopulations in the peritoneal fluid of women with endometriosis. Fertil Steril 1988;50:216-222.
91. Jones RK, Bulmer JN, Searle RF. Phenotypic and functional studies of leukocytes in human endometrium and endometriosis. Hum Reprod Update 1998;4:702-709.
92. Oosterlynck DJ, Cornillie FJ, Waer M et al. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril 1991;56: 45-51.
93. Ota H, Igarashi S. Expression of major histocompatibility complex class II antigen in endometriotic tissue in patients with endometriosis and adenomyosis. Fertil Steril 1993;60:834-838.
94. Semino C, Barocci A, Semino PL et al. Role of major histocompatibilty complex class-I expression and natural killer-like T-cells in the genetic control of endometriosis. Fertil Steril 1995;64:909-916.
95. Somigliana E, Vigano P, Gaffuri B et al. Human endometrial cells as a source of soluble intercellular adhesion molecule (ICAM)-1 molecules. Hum Reprod 1996;11:1190-1194.
96. Vigano P, Gaffuri B, Somogliana E et al. Expression of intercellular adhesion molecule (ICAM) mRNA and protein is enhanced in endometriosis versus endometrial stromal cells in culture. Mol Hum Reprod 1998;4:1150-1156.
97. Sharpe-Timms KL. Endometrial anomalies in women with endometriosis. Ann NY Acad Sci 2001;943:131-147.
98. Tabibzadeh S, Kong QF, Satyaswaroop PG et al. Heat shock proteins in human endometrium throughout the menstrual cycle. Hum Reprod 1996;11:633-640.
99. Jaattela M. Overexpression of major heat shock protein hsp70 inhibits tumour necrosis factor-induced activation of phospholipase A2. Immunology 1993;151:4286-4294.
100. Sattler M, Liang H, Nettesheim D et al. Structure of Bcl-xL-BaK peptide complex: recognition between regulators of endometriosis. Science 1997;225:983-986.
101. Tabibzadeh S, Zupi E, Babaknia A et al. Site and menstrual cycledependent expression of proteins of the tumour necrosis factor (TNF) receptor family, and Bcl-2 oncoprotein and phase-specific production of TNFa in human endometrium. Hum Reprod 1995;10:277-286.
102. Gebel HM, Braun DP, Tambur A et al. Spontaneous apoptosis of endometrial tissue is impaired in women with endometriosis. Fertil Steril 1998;69:1042-1047.
103. Beliard A, Noel A, Foidart JM. Reduction of apoptosis and proliferation in endometriosis. Fertil Steril 2004;82:80-85.
104. Vinatier D, Orazi G, Cosson M et al. Theories on endometriosis. Eur J Obstet Gynecol Reprod Med 2001;96:21-34.
105. Hunt G. The role of laminin in cancer invasion and metastasis. Exp Cell Biol 1989;57:165-176.
106. Lessey BA, Damjanovich L, Coutifaris C et al. Integrin adhesion molecules in the human endometrium. Correlation with the normal and abnormal menstrual cycle. J Clin Invest 1992;90:188-195.
107. Beliard A, Donnez J, Nisolle M et al. Localization of laminin, fibronectin, E-cadherin, and integrins in endometrium and endometriosis. Fertil Steril 1997;67:266-272.
108. Osteen KG, Bruner KL, Sharpe-Timms KL. Steroid and growth factor regulation of matrix metalloproteinase expression and endometriosis. Semin Reprod Endocrinol 1996;14:247-255.
109. Osteen KG, Keller NR, Feltus FA et al. Paracrine regulation of matrix metalloproteinase expression in the normal human endometrium. Gynecol Obstet Invest 1999;48 suppl 1:2-13.
110. Sillem M, Prifti S, Neher M et al. Extracellular matrix remodelling in the endometrium and its possible relevance to the pathogenesis of endometriosis. Steroids 1998;64:648-653.
111. Sharpe-Timms KL, Keisler LW, McIntush EW et al. Tissue inhibitor of metalloproteinase-1 concentrations are attenuated in peritoneal fluid and sera of women with endometriosis and restored in sera by gonadotrophin releasing hormone agonist therapy. Fertil Steril 1998;69:1128-1134.
112. Chung HW, Wen Y, Chun SH et al. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness. Fertil Steril 2001;75:152-159.
113. Cox KE, Piva M, Sharpe-Timms KL. Differential regulation of matrix metalloproteinase-3 gene expression in endometriotic lesions compared with endometrium. Biol Reprod 2001;65:1297-1303.
114. Sharpe-Timms KL, Cox KE. Paracrine regulation of matrix metalloproteinase expression in endometriosis. Ann NY Acad Sci 2002;955:147-156.
115. Pitsos M, Kanakas N. The role of matrix metalloproteinases in the pathogenesis of endometriosis. Reprod Sci 2009;16:717-726.
116. Osteen KG, Bruner-Tran KL, Eisenberg E. Reduced progesterone action during endometrial maturation: a potential risk factor for the development of endometriosis. Fertil Steril 2005;83:529-537.
117. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 2003;200:448-464.
118. May K, Becker CM. Endometriosis and angiogenesis. Minerva Ginecol 2009;60:245-254.
119. Taylor RN, Yu J, Torres PB et al. Mechanistic and therapeutic implications of angiogenesis in endometriosis. Reprod Sci 2009;16:140-146.
120. Bourlev V, Volkov N, Pavlovitch S et al. The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions. Reproduction 2006;132:501-509.
121. Di Carlo C, Bonifacio M, Tommaselli GA et al. Metalloproteinases, vascular endothelial growth factor, and angiopoietin 1 and 2 in eutopic and ectopic endometrium. Fertil Steril 2009;91:2315-2323.
122. Sanfilippo JS, Wakim NG, Schikler KN et al. Endometriosis in association with uterine anomaly. Am J Obstet Gynecol 1986;154:39-43.
123. Salamanca A, Beltran E. Subendothelial contractibility in menstrual phase visualized by transvaginal sonography in patients with endometriosis. Fertil Steril 1995;64:193-195.
124. Ayers JWT, Friedman AP. Utero-tubal hypotonia associated with pelvic endometriosis. American Fertility Society Annual Meeting, 1985, Abstract 131.
125. Darrow SL, Vena JE, Batt RE et al. Menstrual cycle characteristics and the risk of endometriosis. Epidemiology 1993;4:135-142.
126. Vercellini P, de Giorgi O, Aimi G et al. Menstrual characteristics in women with and without endometriosis. Obstet Gynecol 1997;90:264-268.
127. Martinez-Roman S, Balasch J, Creus M et al. Transferrin receptor (CD71) expression in peritoneal macrophages from fertile and infertile women with and without endometriosis. Am J Reprod Immunol 1997;38:413-417.
128. Raiter-Tenenbaum A, Baranao RI, Etchepareborda JJ et al. Functional and phenotypic alterations in peritoneal macrophages from patients with early and advanced endometriosis. Arch Gynecol Obstet 1998;261:147-157.
129. McLaren J, Prentice A, Charnock-Jones DS et al. Immunolocalization of the apoptosis regulating proteins Bcl-2 and bax in human endometrium and isolated peritoneal fluid macrophages in endometriosis. Hum Reprod 1997;12:146-152.
130. McLaren J, Dealtry G, Prentice A et al. decreased levels of the potent regulator of monocyte/macrophage activation, interleukin-13, in the peritoneal fluid of patients with endometriosis. Hum Reprod 1997;12:1307-1310.
131. Halme J, Becker S, Wing R. Accentuated cyclic activation of peritoneal macrophages in patients with endometriosis. Am J Obstet Gynecol 1984;148:85-90.
132. Simpson JL, Bischoff FZ, Kamat A et al. Genetics of endometriosis. Obstet Gynecol Clin North Am 2003;30:21-40.
133. Hadfield RM, Mardon HJ, Barlow DH et al. Endometriosis in monozygotic twins. Fertil Steril 1997;68:941-942.
134. Treloar SA, O'Connor DT, O'Connor VM et al. Genetic influences on endometriosis in an Australian twin sample. Fertil Steril 1997;71:701-710.
135. Zondervan K, Cardon L, Kennedy S. Development of a website for the genetic epidemiology of endometriosis. Fertil Steril 2002;78:777-781.
136. Guo SW. Epigenetics of endometriosis. Molec Hum Reprod 2009;15:587-607.